Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long Is Long Enough?

Literature DB >> 30882137

Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long Is Long Enough?

Valeria Fabre¹, Joe Amoah², Sara E Cosgrove¹, Pranita D Tamma².

Abstract

In a multicenter, observational, propensity-score-weighted cohort of 249 adults with uncomplicated Pseudomonas aeruginosa bacteremia, patients receiving short-course (median, 9 days; interquartile range [IQR], 8-10) therapy had a similar odds of recurrent infection or death within 30 days as those receiving longer courses (median, 16 days; IQR, 14-17).

Entities: Disease Species

Keywords: zzm321990 Pseudomonas aeruginosazzm321990 ; cefepime; gram-negative bacteremia; piperacillin-tazobactam; treatment duration

Year: 2019 PMID： 30882137 PMCID： PMC7320076 DOI： 10.1093/cid/ciz223

Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 9.079

12 in total

1. Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial.

Authors: Dafna Yahav; Erica Franceschini; Fidi Koppel; Adi Turjeman; Tanya Babich; Roni Bitterman; Ami Neuberger; Nesrin Ghanem-Zoubi; Antonella Santoro; Noa Eliakim-Raz; Barak Pertzov; Tali Steinmetz; Anat Stern; Yaakov Dickstein; Elias Maroun; Hiba Zayyad; Jihad Bishara; Danny Alon; Yonatan Edel; Elad Goldberg; Claudia Venturelli; Cristina Mussini; Leonard Leibovici; Mical Paul
Journal: Clin Infect Dis Date: 2019-09-13 Impact factor: 9.079

2. Trial of short-course antimicrobial therapy for intraabdominal infection.

Authors: Robert G Sawyer; Jeffrey A Claridge; Avery B Nathens; Ori D Rotstein; Therese M Duane; Heather L Evans; Charles H Cook; Patrick J O'Neill; John E Mazuski; Reza Askari; Mark A Wilson; Lena M Napolitano; Nicholas Namias; Preston R Miller; E Patchen Dellinger; Christopher M Watson; Raul Coimbra; Daniel L Dent; Stephen F Lowry; Christine S Cocanour; Michaela A West; Kaysie L Banton; William G Cheadle; Pamela A Lipsett; Christopher A Guidry; Kimberley Popovsky
Journal: N Engl J Med Date: 2015-05-21 Impact factor: 91.245

3. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.

Authors: D A Talan; W E Stamm; T M Hooton; G J Moran; T Burke; A Iravani; J Reuning-Scherer; D A Church
Journal: JAMA Date: 2000 Mar 22-29 Impact factor: 56.272

4. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.

Authors: Rachida el Moussaoui; Corianne A J M de Borgie; Peterhans van den Broek; Willem N Hustinx; Paul Bresser; Guido E L van den Berk; Jan-Werner Poley; Bob van den Berg; Frans H Krouwels; Marc J M Bonten; Carla Weenink; Patrick M M Bossuyt; Peter Speelman; Brent C Opmeer; Jan M Prins
Journal: BMJ Date: 2006-06-10

5. Association of Adverse Events With Antibiotic Use in Hospitalized Patients.

Authors: Pranita D Tamma; Edina Avdic; David X Li; Kathryn Dzintars; Sara E Cosgrove
Journal: JAMA Intern Med Date: 2017-09-01 Impact factor: 21.873

6. Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis.

Authors: Matthew J Hepburn; David P Dooley; Peter J Skidmore; Michael W Ellis; William F Starnes; William C Hasewinkle
Journal: Arch Intern Med Date: 2004 Aug 9-23

7. Comparing the Outcomes of Adults With Enterobacteriaceae Bacteremia Receiving Short-Course Versus Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score-Matched Cohort.

Authors: Darunee Chotiprasitsakul; Jennifer H Han; Sara E Cosgrove; Anthony D Harris; Ebbing Lautenbach; Anna T Conley; Pam Tolomeo; Jacqueleen Wise; Pranita D Tamma
Journal: Clin Infect Dis Date: 2018-01-06 Impact factor: 9.079

8. Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia.

Authors: Pranita D Tamma; Anna T Conley; Sara E Cosgrove; Anthony D Harris; Ebbing Lautenbach; Joe Amoah; Edina Avdic; Pam Tolomeo; Jacqueleen Wise; Sonia Subudhi; Jennifer H Han
Journal: JAMA Intern Med Date: 2019-03-01 Impact factor: 21.873

9. Ultra-Short-Course Antibiotics for Patients With Suspected Ventilator-Associated Pneumonia but Minimal and Stable Ventilator Settings.

Authors: Michael Klompas; Lingling Li; John T Menchaca; Susan Gruber
Journal: Clin Infect Dis Date: 2017-04-01 Impact factor: 9.079

Review 10. How to manage Pseudomonas aeruginosa infections.

Authors: Matteo Bassetti; Antonio Vena; Antony Croxatto; Elda Righi; Benoit Guery
Journal: Drugs Context Date: 2018-05-29

9 in total

1. Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections in Children: Translating Evidence From Adults Into Pediatric Practice.

Authors: Rebecca G Same; Alice J Hsu; Pranita D Tamma
Journal: J Pediatric Infect Dis Soc Date: 2019-11-06 Impact factor: 3.164

Review 2. Antimicrobial Stewardship Interventions to Combat Antibiotic Resistance: an Update on Targeted Strategies.

Authors: Kelli A Cole; Kaitlyn R Rivard; Lisa E Dumkow
Journal: Curr Infect Dis Rep Date: 2019-08-31 Impact factor: 3.663

3. Impact of an Antimicrobial Stewardship Bundle for Uncomplicated Gram-Negative Bacteremia.

Authors: Reaghan M Erickson; Brandon J Tritle; Emily S Spivak; Tristan T Timbrook
Journal: Open Forum Infect Dis Date: 2019-11-13 Impact factor: 3.835

4. Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections: Consensus Guidance Using a Modified Delphi Process.

Authors: Emily L Heil; Jacqueline T Bork; Lilian M Abbo; Tamar F Barlam; Sara E Cosgrove; Angelina Davis; David R Ha; Timothy C Jenkins; Keith S Kaye; James S Lewis; Jessica K Ortwine; Jason M Pogue; Emily S Spivak; Michael P Stevens; Liza Vaezi; Pranita D Tamma
Journal: Open Forum Infect Dis Date: 2021-10-11 Impact factor: 3.835

5. Impact of a Laboratory-Developed Phenotypic Rapid Susceptibility Test Directly From Positive Blood Cultures on Time to Narrowest Effective Therapy in Patients With Gram-Negative Bacteremia: A Prospective Randomized Trial.

Authors: Alyssa B Christensen; Brent Footer; Tobias Pusch; Kim Heath; Maha Iqbal; Lian Wang; Gregory Tallman; Cameron Cover; Jennifer Marfori; Brian Kendall; Nick Stucky; Meagan Greckel; Ivor L Thomas; Katelynn Tran; Salena Yip; Margret Oethinger
Journal: Open Forum Infect Dis Date: 2022-07-22 Impact factor: 4.423

6. Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study.

Authors: Tanya Babich; Pontus Naucler; John Karlsson Valik; Christian G Giske; Natividad Benito; Ruben Cardona; Alba Rivera; Celine Pulcini; Manal Abdel Fattah; Justine Haquin; Alasdair Macgowan; Sally Grier; Bibiana Chazan; Anna Yanovskay; Ronen Ben Ami; Michal Landes; Lior Nesher; Adi Zaidman-Shimshovitz; Kate McCarthy; David L Paterson; Evelina Tacconelli; Michael Buhl; Susanna Mauer; Jesús Rodríguez-Baño; Marina de Cueto; Antonio Oliver; Enrique Ruiz de Gopegui; Angela Cano; Isabel Machuca; Monica Gozalo-Marguello; Luis Martinez-Martinez; Eva M Gonzalez-Barbera; Iris Gomez Alfaro; Miguel Salavert; Bojana Beovic; Andreja Saje; Manica Mueller-Premru; Leonardo Pagani; Virginie Vitrat; Diamantis Kofteridis; Maria Zacharioudaki; Sofia Maraki; Yulia Weissman; Mical Paul; Yaakov Dickstein; Leonard Leibovici; Dafna Yahav
Journal: Infect Dis Ther Date: 2022-05-25